What Huntsman’s latest earnings mean for shareholders
Huntsman (HUN) recently reported fourth quarter and full year 2025 results, showing lower sales and a larger annual net loss, developments that help explain the stock’s recent moves.
For the fourth quarter, Huntsman reported sales of US$1,355 million compared with US$1,452 million a year earlier. The company posted a net loss of US$96 million, compared with a net loss of US$141 million in the prior year period.
Basic and diluted loss per share for the quarter were US$0.56, compared with US$0.82 a year ago. These figures outline the earnings pressure the business is working through, even as quarterly losses narrowed.
For the full year 2025, sales were US$5,683 million, compared with US$6,036 million a year earlier. The company reported a net loss of US$284 million for the year, compared with a net loss of US$189 million in the prior year.
On a per share basis, basic and diluted loss for 2025 were US$1.65, compared with US$1.10 a year earlier. That step up in annual loss per share sits at the center of the current investment debate around Huntsman.
See our latest analysis for Huntsman.
Huntsman’s earnings release and dividend declaration came after a strong 30 day share price return of 13.68% and 90 day share price return of 18.73%. However, the 1 year total shareholder return of 17.94% decline and 3 year total shareholder return of 50.91% decline suggest longer term momentum has been weak and that recent gains may reflect shifting expectations around future risks and potential improvement.
If this earnings report has you reassessing materials names, it could be a good moment to scan other opportunities, including 8 top copper producer stocks that may fit your risk and return preferences.
With Huntsman shares up around 21% year to date but still carrying a full year loss, investors are asking a simple question: is this recent rebound a chance to buy in, or is the market already pricing in future growth?
Most Popular Narrative: 27.9% Overvalued
At a last close of $12.30 versus a widely followed fair value estimate of $9.62, Huntsman’s current price sits well above that narrative anchor, which is built around projected earnings recovery and margin repair over the next few years.
Cost optimization, working capital discipline, and strategic asset closures (e.g., the maleic anhydride facility in Europe) are expected to enhance free cash flow generation and support improved net margins and earnings resilience during the next macro upturn.
Curious how an unprofitable chemicals group still commands a premium to its fair value line? The story leans heavily on future margin repair, stronger earnings, and a richer profit multiple than the sector usually gives this kind of profile. Want to see exactly which revenue, margin, and earnings paths need to line up to support that view?
Result: Fair Value of $9.62 (OVERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, sustained MDI overcapacity and soft construction demand could keep pricing under pressure and make the earnings recovery story much harder to play out.
Find out about the key risks to this Huntsman narrative.
Another angle on Huntsman’s valuation
So far, the fair value story has leaned on future earnings and a premium multiple that leaves Huntsman looking overvalued versus a $9.62 anchor. Yet on today’s numbers, the P/S of 0.4x is far lower than the US Chemicals industry at 1.2x and peers at 1.3x, and even below an estimated fair ratio of 0.9x. That wide gap suggests the market already prices in plenty of execution and end market risk, which raises a simple question for you as an investor: is this discount a warning sign, or a potential entry point if the turnaround thesis plays out?
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Given the mix of pressure points and potential upside running through this story, it makes sense to check the underlying data yourself and move quickly to form your own stance. To see how the risk and reward signals balance out in one place, take a look at our breakdown of 2 key rewards and 2 important warning signs.
Looking for more investment ideas?
If Huntsman has sharpened your focus, do not stop here. Use this momentum to actively search for other opportunities that better match your goals and risk comfort.
- Target value opportunities that balance quality with price by scanning our list of 45 high quality undervalued stocks and see which ones fit your watchlist.
- Strengthen the defensive side of your portfolio by reviewing solid balance sheet and fundamentals stocks screener (41 results), where companies with sturdier financials may help steady overall returns.
- Get ahead of the crowd by checking screener containing 24 high quality undiscovered gems, so you are not the investor hearing about compelling ideas only after they have moved.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com